Trademark Overview
On Friday, August 8, 2025, a trademark application was filed for PKX BIO with the United States Patent and Trademark Office. The USPTO has given the PKX BIO trademark a serial number of 99328081. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, August 8, 2025. This trademark is owned by Bexson Biomedical, Inc.. The PKX BIO trademark is filed in the Chemical Products, Pharmaceutical Products, Medical Instrument Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders
Chemicals, namely, cyclodextrins for industrial purposes; preparations derived from cyclodextrins, namely, chemicals for industrial purposes and active principles in the nature of active chemical ingredients, complexed by cyclodextrins, for use in the manufacture of pharmaceuticals and medicines; chemicals, namely, cyclodextrins and cyclodextrin derivatives for use in the chemical, plastics, paper, agricultural, horticultural, insulation, packaging, pharmaceutical, cosmetic, fragrance, textile, leather, healthcare, food and paint industries; active pharmaceutical ingredients, namely, salts for use in the manufacture of pharmaceuticals and medicines
research and development in the field of computational biology, bioinformatics, genomics, biotechnology, immunology and pharmaceuticals; biomedical research and development services; scientific study and research in the fields of medicine, biomedical technology, and genetics
wearable drug delivery devices sold empty, namely, subcutaneous pumps for the delivery of medication for viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system-related diseases and disorders
medical and scientific research in the fields of autoimmune, cardiovascular, central nervous system, endocrine, gastrointestinal, genetic, infectious, inflammatory, kidney, liver, menopausal, metabolic, musculoskeletal, neurodegenerative, neurological, neuromuscular and viral diseases and disorders; platforms for small molecules for controlled delivery of therapeutic agents; medical and scientific research and development in relation to pharmaceuticals and drug delivery platforms; providing scientific information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor; pharmaceutical research and development; drug discovery services; providing medical information, advisory, and consultancy services relating to pharmaceuticals and drug delivery devices therefor; technical scientific consultation and product development for others in the field of biotechnology and development of pharmaceuticals
